Singular Genomics Systems (OMIC)
(Delayed Data from NSDQ)
$14.76 USD
+0.49 (3.44%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $14.43 -0.33 (-2.24%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OMIC 14.76 +0.49(3.44%)
Will OMIC be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for OMIC based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for OMIC
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
Deals this week: Smartsheet, AT&T, BP, Cleveland-Cliffs, Vistra and more
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
Video: Thursday 9/19 Insider Buying Report: OMIC, WSC